Damora Therapeutics Inc.

DMRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.20

-$0.65 (-2.84%)

Sep 22, 2026, 2:33 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	257.62M	14.18M	21.47M	32.79M	62.56M	163.58M
Short-Term Investments	n/a	n/a	11.69M	27.44M	37.63M	n/a
Long-Term Investments	n/a	n/a	n/a	5.83M	9.05M	254K
Other Long-Term Assets	n/a	163K	1.13M	2.28M	2.03M	1.16M
Receivables	899K	881K	1.72M	1.38M	2.28M	2.21M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.32M	1.19M	1.13M	1.5M	5.9M	1.86M
Total Current Assets	260.42M	16.84M	36.77M	63.91M	110.1M	169.3M
Property-Plant & Equipment	104K	130K	325K	1.17M	1.04M	885K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	104K	293K	1.45M	9.28M	12.11M	2.3M
Total Assets	260.53M	17.13M	38.23M	73.19M	122.22M	171.6M
Account Payables	444K	377K	1.7M	3.35M	1.53M	2.85M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	12K	183K	476K	399K	374K
Other Current Liabilities	1.52M	604K	2.96M	6.68M	2.01M	1.31M
Total Current Liabilities	20.07M	1.2M	5.83M	11.11M	4.54M	5.57M
Long-Term Debt	n/a	1.36M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	28K	43K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	81K	1.46M	66K	328K	448K	541K
Total Liabilities	20.15M	2.66M	5.9M	11.44M	4.99M	6.11M
Total Debt	68K	1.43M	249K	804K	847K	915K
Book Value	240.38M	14.47M	32.33M	61.75M	117.22M	165.49M
Book Value Per Share	176.36	12.51	30.42	60.76	116.01	163.77
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-487.36M	-277.52M	-256.08M	-217.74M	-156.11M	-104.36M
Comprehensive Income	802K	97K	380K	-244K	-320K	674K
Shareholders Equity	240.38M	14.47M	32.33M	61.75M	117.22M	165.49M
Total Investments	n/a	n/a	11.69M	33.27M	46.68M	254K